Lv4
496 积分 2025-06-05 加入
A Clinical-Stage Inhaled RNAi Therapeutic For Pulmonary Inflammation Mediates Durable RAGE Silencing In Nonhuman Primates (NHP)
1年前
已关闭
A Lung-Targeted RNAi Therapeutics Delivery Platform Compatible With Subcutaneous (s.c.) Administration Mediates Pulmonary RAGE Silencing In Rodents And Nonhuman Primates
1年前
已关闭
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
1年前
已完结
Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs
1年前
已完结
皖公网安备34019202002308
